Literature DB >> 11008484

Cyclic nucleotide phosphodiesterases: relating structure and function.

S H Francis1, I V Turko, J D Corbin.   

Abstract

Cyclic nucleotide phosphodiesterases (PDEs) comprise a superfamily of metallophosphohydrolases that specifically cleave the 3',5'-cyclic phosphate moiety of cAMP and/or cGMP to produce the corresponding 5'-nucleotide. PDEs are critical determinants for modulation of cellular levels of cAMP and/or cGMP by many stimuli. Eleven families of PDEs with varying selectivities for cAMP or cGMP have been identified in mammalian tissues. Within these families, multiple isoforms are expressed either as products of different genes or as products of the same gene through alternative splicing. Regulation of PDEs is important for controlling myriad physiological functions, including the visual response, smooth muscle relaxation, platelet aggregation, fluid homeostasis, immune responses, and cardiac contractility. PDEs are critically involved in feedback control of cellular cAMP and cGMP levels. Activities of the various PDEs are highly regulated by a panoply of processes, including phosphorylation events, interaction with small molecules such as cGMP or phosphatidic acid, subcellular localization, and association with specific protein partners. The PDE superfamily continues to be a major target for pharmacological intervention in a number of medically important maladies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11008484     DOI: 10.1016/s0079-6603(00)65001-8

Source DB:  PubMed          Journal:  Prog Nucleic Acid Res Mol Biol        ISSN: 0079-6603


  101 in total

Review 1.  The many dimensions of cAMP signaling.

Authors:  J H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.

Authors:  Jun Kotera; Kennard A Grimes; Jackie D Corbin; Sharron H Francis
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

3.  Identification and characterization of two unusual cGMP-stimulated phoshodiesterases in dictyostelium.

Authors:  Leonard Bosgraaf; Henk Russcher; Helena Snippe; Sonya Bader; Joyce Wind; Peter J M Van Haastert
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

4.  PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.

Authors:  Jennifer J Carlisle Michel; Kimberly L Dodge; Wei Wong; Nicole C Mayer; Lorene K Langeberg; John D Scott
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

5.  In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation.

Authors:  Florian Mullershausen; Michael Russwurm; Doris Koesling; Andreas Friebe
Journal:  Mol Biol Cell       Date:  2004-07-07       Impact factor: 4.138

6.  Phosphodiesterase 3A binds to 14-3-3 proteins in response to PMA-induced phosphorylation of Ser428.

Authors:  Mercedes Pozuelo Rubio; David G Campbell; Nicholas A Morrice; Carol Mackintosh
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

Review 7.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

8.  PDE1B2 regulates cGMP and a subset of the phenotypic characteristics acquired upon macrophage differentiation from a monocyte.

Authors:  Andrew T Bender; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

9.  Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes.

Authors:  Mark T Ziolo; Susanne J Lewandowski; Jacquelyn M Smith; Fred D Romano; Gordon M Wahler
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

10.  Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility.

Authors:  Silvia Masciarelli; Kathleen Horner; Chengyu Liu; Sun Hee Park; Mary Hinckley; Steven Hockman; Taku Nedachi; Catherine Jin; Marco Conti; Vincent Manganiello
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.